Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease

Celiac disease is triggered by partially digested gluten proteins. Enzyme therapies that complete protein digestion in vivo could support a gluten-free diet, but the barrier to completeness is high. Current options require enzyme amounts on the same order as the protein meal itself. In this study, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Rey, Martial, Yang, Menglin, Lee, Linda, Zhang, Ye, Sheff, Joey G., Sensen, Christoph W., Mrazek, Hynek, Halada, Petr, Man, Petr, McCarville, Justin L, Verdu, Elena F., Schriemer, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969619/
https://www.ncbi.nlm.nih.gov/pubmed/27481162
http://dx.doi.org/10.1038/srep30980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969619/
https://www.ncbi.nlm.nih.gov/pubmed/27481162
http://dx.doi.org/10.1038/srep30980

Ejemplares similares